APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Short-Acting Anesthetic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Short-Acting Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174035220330 December 2025196 pages

Choose your research edition.

Industry ResearchShort-Acting Anesthetic Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-Acting Anesthetic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Short-Acting Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-Acting Anesthetic Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-Acting Anesthetic Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Short-Acting Anesthetic market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Short-Acting Anesthetic include Aspen Pharmacare, Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius-Kabi, Hikma Pharmaceuticals, Hospira, Paion, Piramal Critical Care and Septodont, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Short-Acting Anesthetic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Short-Acting Anesthetic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Short-Acting Anesthetic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Short-Acting Anesthetic market size, projected growth trends, production technologies, key applications, and end-use industries.

Short-Acting Anesthetic Segment by Company

Aspen Pharmacare

Baxter Healthcare

Dr. Reddy's Laboratories

Fresenius-Kabi

Hikma Pharmaceuticals

Hospira

Paion

Piramal Critical Care

Septodont

AstraZeneca

AbbVie

B. Braun

Cisen Pharmaceutical

Pfizer

Yingke Biopharmaceutical

SSY Group

Baili-Pharm

Eisai

Short-Acting Anesthetic Segment by Type

Local

General

Short-Acting Anesthetic Segment by Application

Hospital

Clinic

Short-Acting Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-Acting Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-Acting Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-Acting Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Short-Acting Anesthetic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Short-Acting Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Short-Acting Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Short-Acting Anesthetic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Short-Acting Anesthetic Industry Trends Table 2. Short-Acting Anesthetic Industry Drivers Table 3. Short-Acting Anesthetic Industry Opportunities and Challenges Table 4. Short-Acting Anesthetic Industry Restraints Table 5. Global Short-Acting Anesthetic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Short-Acting Anesthetic Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Short-Acting Anesthetic Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Short-Acting Anesthetic Sales Market Share by Manufacturers Table 9. Global Short-Acting Anesthetic Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Short-Acting Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Short-Acting Anesthetic Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Short-Acting Anesthetic Manufacturers, Product Type & Application Table 13. Global Short-Acting Anesthetic Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Short-Acting Anesthetic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Local Table 17. Major Manufacturers of General Table 18. Global Short-Acting Anesthetic Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 20. Global Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 21. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2026) Table 22. Global Short-Acting Anesthetic Sales Market Share by Type (2027-2032) Table 23. Global Short-Acting Anesthetic Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Short-Acting Anesthetic Revenue by Type (2021-2026) & (K Units) Table 25. Global Short-Acting Anesthetic Revenue by Type (2027-2032) & (K Units) Table 26. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2026) Table 27. Global Short-Acting Anesthetic Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Short-Acting Anesthetic Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 32. Global Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 33. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2026) Table 34. Global Short-Acting Anesthetic Sales Market Share by Application (2027-2032) Table 35. Global Short-Acting Anesthetic Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Short-Acting Anesthetic Revenue by Application (2021-2026) & (K Units) Table 37. Global Short-Acting Anesthetic Revenue by Application (2027-2032) & (K Units) Table 38. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2026) Table 39. Global Short-Acting Anesthetic Revenue Market Share by Application (2027-2032) Table 40. Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Short-Acting Anesthetic Sales by Region (2021-2026) & (K Units) Table 42. Global Short-Acting Anesthetic Sales Market Share by Region (2021-2026) Table 43. Global Short-Acting Anesthetic Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Short-Acting Anesthetic Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 47. North America Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 48. Europe Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 50. Europe Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 57. Global Short-Acting Anesthetic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Short-Acting Anesthetic Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Short-Acting Anesthetic Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2026) Table 61. Global Short-Acting Anesthetic Revenue Market Share by Region (2027-2032) Table 62. Aspen Pharmacare Company Information Table 63. Aspen Pharmacare Business Overview Table 64. Aspen Pharmacare Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Aspen Pharmacare Short-Acting Anesthetic Product Portfolio Table 66. Aspen Pharmacare Recent Development Table 67. Baxter Healthcare Company Information Table 68. Baxter Healthcare Business Overview Table 69. Baxter Healthcare Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Baxter Healthcare Short-Acting Anesthetic Product Portfolio Table 71. Baxter Healthcare Recent Development Table 72. Dr. Reddy's Laboratories Company Information Table 73. Dr. Reddy's Laboratories Business Overview Table 74. Dr. Reddy's Laboratories Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio Table 76. Dr. Reddy's Laboratories Recent Development Table 77. Fresenius-Kabi Company Information Table 78. Fresenius-Kabi Business Overview Table 79. Fresenius-Kabi Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Fresenius-Kabi Short-Acting Anesthetic Product Portfolio Table 81. Fresenius-Kabi Recent Development Table 82. Hikma Pharmaceuticals Company Information Table 83. Hikma Pharmaceuticals Business Overview Table 84. Hikma Pharmaceuticals Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio Table 86. Hikma Pharmaceuticals Recent Development Table 87. Hospira Company Information Table 88. Hospira Business Overview Table 89. Hospira Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hospira Short-Acting Anesthetic Product Portfolio Table 91. Hospira Recent Development Table 92. Paion Company Information Table 93. Paion Business Overview Table 94. Paion Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Paion Short-Acting Anesthetic Product Portfolio Table 96. Paion Recent Development Table 97. Piramal Critical Care Company Information Table 98. Piramal Critical Care Business Overview Table 99. Piramal Critical Care Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Piramal Critical Care Short-Acting Anesthetic Product Portfolio Table 101. Piramal Critical Care Recent Development Table 102. Septodont Company Information Table 103. Septodont Business Overview Table 104. Septodont Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Septodont Short-Acting Anesthetic Product Portfolio Table 106. Septodont Recent Development Table 107. AstraZeneca Company Information Table 108. AstraZeneca Business Overview Table 109. AstraZeneca Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. AstraZeneca Short-Acting Anesthetic Product Portfolio Table 111. AstraZeneca Recent Development Table 112. AbbVie Company Information Table 113. AbbVie Business Overview Table 114. AbbVie Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. AbbVie Short-Acting Anesthetic Product Portfolio Table 116. AbbVie Recent Development Table 117. B. Braun Company Information Table 118. B. Braun Business Overview Table 119. B. Braun Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. B. Braun Short-Acting Anesthetic Product Portfolio Table 121. B. Braun Recent Development Table 122. Cisen Pharmaceutical Company Information Table 123. Cisen Pharmaceutical Business Overview Table 124. Cisen Pharmaceutical Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio Table 126. Cisen Pharmaceutical Recent Development Table 127. Pfizer Company Information Table 128. Pfizer Business Overview Table 129. Pfizer Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Pfizer Short-Acting Anesthetic Product Portfolio Table 131. Pfizer Recent Development Table 132. Yingke Biopharmaceutical Company Information Table 133. Yingke Biopharmaceutical Business Overview Table 134. Yingke Biopharmaceutical Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio Table 136. Yingke Biopharmaceutical Recent Development Table 137. SSY Group Company Information Table 138. SSY Group Business Overview Table 139. SSY Group Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. SSY Group Short-Acting Anesthetic Product Portfolio Table 141. SSY Group Recent Development Table 142. Baili-Pharm Company Information Table 143. Baili-Pharm Business Overview Table 144. Baili-Pharm Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Baili-Pharm Short-Acting Anesthetic Product Portfolio Table 146. Baili-Pharm Recent Development Table 147. Eisai Company Information Table 148. Eisai Business Overview Table 149. Eisai Short-Acting Anesthetic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Eisai Short-Acting Anesthetic Product Portfolio Table 151. Eisai Recent Development Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Short-Acting Anesthetic Distributors List Table 155. Short-Acting Anesthetic Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Short-Acting Anesthetic Product Image Figure 2. Global Short-Acting Anesthetic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short-Acting Anesthetic Market Size (2021-2032) & (US$ Million) Figure 4. Global Short-Acting Anesthetic Sales (2021-2032) & (K Units) Figure 5. Global Short-Acting Anesthetic Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Short-Acting Anesthetic Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Local Image Figure 9. General Image Figure 10. Global Short-Acting Anesthetic Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Short-Acting Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032) Figure 13. Global Short-Acting Anesthetic Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Short-Acting Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Short-Acting Anesthetic Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Short-Acting Anesthetic Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032) Figure 21. Global Short-Acting Anesthetic Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Short-Acting Anesthetic Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032) Figure 24. North America Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 26. U.S. Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 31. Germany Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 38. China Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 46. Brazil Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Short-Acting Anesthetic Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Short-Acting Anesthetic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Short-Acting Anesthetic Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Figure 57. North America Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Figure 59. Europe Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Short-Acting Anesthetic Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Short-Acting Anesthetic Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Short-Acting Anesthetic Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Local
  • General
Applications
  • Hospital
  • Clinic
Companies covered
  • Aspen Pharmacare
  • Baxter Healthcare
  • Dr. Reddy's Laboratories
  • Fresenius-Kabi
  • Hikma Pharmaceuticals
  • Hospira
  • Paion
  • Piramal Critical Care
  • Septodont
  • AstraZeneca
  • AbbVie
  • B. Braun
  • Cisen Pharmaceutical
  • Pfizer
  • Yingke Biopharmaceutical
  • SSY Group
  • Baili-Pharm
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Short-Acting Anesthetic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Short-Acting Anesthetic Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Short-Acting Anesthetic Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Short-Acting Anesthetic Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Short-Acting Anesthetic Market Dynamics
  1. 2.1 Short-Acting Anesthetic Industry Trends
  2. 2.2 Short-Acting Anesthetic Industry Drivers
  3. 2.3 Short-Acting Anesthetic Industry Opportunities and Challenges
  4. 2.4 Short-Acting Anesthetic Industry Restraints
3 Short-Acting Anesthetic Market by Manufacturers
  1. 3.1 Global Short-Acting Anesthetic Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Short-Acting Anesthetic Sales by Manufacturers (2021-2026)
  3. 3.3 Global Short-Acting Anesthetic Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Short-Acting Anesthetic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Short-Acting Anesthetic Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Short-Acting Anesthetic Manufacturers, Product Type & Application
  7. 3.7 Global Short-Acting Anesthetic Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Short-Acting Anesthetic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Short-Acting Anesthetic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Short-Acting Anesthetic Tier 1, Tier 2, and Tier 3
4 Short-Acting Anesthetic Market by Type
  1. 4.1 Short-Acting Anesthetic Type Introduction
  2. 4.1.1 Local
  3. 4.1.2 General
  4. 4.2 Global Short-Acting Anesthetic Sales by Type
  5. 4.2.1 Global Short-Acting Anesthetic Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Short-Acting Anesthetic Sales by Type (2021-2032)
  7. 4.2.3 Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032)
  8. 4.3 Global Short-Acting Anesthetic Revenue by Type
  9. 4.3.1 Global Short-Acting Anesthetic Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Short-Acting Anesthetic Revenue by Type (2021-2032)
  11. 4.3.3 Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032)
5 Short-Acting Anesthetic Market by Application
  1. 5.1 Short-Acting Anesthetic Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Short-Acting Anesthetic Sales by Application
  5. 5.2.1 Global Short-Acting Anesthetic Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Short-Acting Anesthetic Sales by Application (2021-2032)
  7. 5.2.3 Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032)
  8. 5.3 Global Short-Acting Anesthetic Revenue by Application
  9. 5.3.1 Global Short-Acting Anesthetic Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Short-Acting Anesthetic Revenue by Application (2021-2032)
  11. 5.3.3 Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032)
6 Global Short-Acting Anesthetic Sales by Region
  1. 6.1 Global Short-Acting Anesthetic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Short-Acting Anesthetic Sales by Region (2021-2032)
  3. 6.2.1 Global Short-Acting Anesthetic Sales by Region (2021-2026)
  4. 6.2.2 Global Short-Acting Anesthetic Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Short-Acting Anesthetic Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Short-Acting Anesthetic Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Short-Acting Anesthetic Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Short-Acting Anesthetic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Short-Acting Anesthetic Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Short-Acting Anesthetic Revenue by Region
  1. 7.1 Global Short-Acting Anesthetic Revenue by Region
  2. 7.1.1 Global Short-Acting Anesthetic Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Short-Acting Anesthetic Revenue by Region (2021-2026)
  4. 7.1.3 Global Short-Acting Anesthetic Revenue by Region (2027-2032)
  5. 7.1.4 Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Short-Acting Anesthetic Revenue (2021-2032)
  8. 7.2.2 North America Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Short-Acting Anesthetic Revenue (2021-2032)
  11. 7.3.2 Europe Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Short-Acting Anesthetic Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Short-Acting Anesthetic Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Short-Acting Anesthetic Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Pharmacare
  2. 8.1.1 Aspen Pharmacare Company Information
  3. 8.1.2 Aspen Pharmacare Business Overview
  4. 8.1.3 Aspen Pharmacare Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Pharmacare Short-Acting Anesthetic Product Portfolio
  6. 8.1.5 Aspen Pharmacare Recent Developments
  7. 8.2 Baxter Healthcare
  8. 8.2.1 Baxter Healthcare Company Information
  9. 8.2.2 Baxter Healthcare Business Overview
  10. 8.2.3 Baxter Healthcare Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Healthcare Short-Acting Anesthetic Product Portfolio
  12. 8.2.5 Baxter Healthcare Recent Developments
  13. 8.3 Dr. Reddy's Laboratories
  14. 8.3.1 Dr. Reddy's Laboratories Company Information
  15. 8.3.2 Dr. Reddy's Laboratories Business Overview
  16. 8.3.3 Dr. Reddy's Laboratories Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio
  18. 8.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 8.4 Fresenius-Kabi
  20. 8.4.1 Fresenius-Kabi Company Information
  21. 8.4.2 Fresenius-Kabi Business Overview
  22. 8.4.3 Fresenius-Kabi Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius-Kabi Short-Acting Anesthetic Product Portfolio
  24. 8.4.5 Fresenius-Kabi Recent Developments
  25. 8.5 Hikma Pharmaceuticals
  26. 8.5.1 Hikma Pharmaceuticals Company Information
  27. 8.5.2 Hikma Pharmaceuticals Business Overview
  28. 8.5.3 Hikma Pharmaceuticals Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio
  30. 8.5.5 Hikma Pharmaceuticals Recent Developments
  31. 8.6 Hospira
  32. 8.6.1 Hospira Company Information
  33. 8.6.2 Hospira Business Overview
  34. 8.6.3 Hospira Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hospira Short-Acting Anesthetic Product Portfolio
  36. 8.6.5 Hospira Recent Developments
  37. 8.7 Paion
  38. 8.7.1 Paion Company Information
  39. 8.7.2 Paion Business Overview
  40. 8.7.3 Paion Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Paion Short-Acting Anesthetic Product Portfolio
  42. 8.7.5 Paion Recent Developments
  43. 8.8 Piramal Critical Care
  44. 8.8.1 Piramal Critical Care Company Information
  45. 8.8.2 Piramal Critical Care Business Overview
  46. 8.8.3 Piramal Critical Care Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Piramal Critical Care Short-Acting Anesthetic Product Portfolio
  48. 8.8.5 Piramal Critical Care Recent Developments
  49. 8.9 Septodont
  50. 8.9.1 Septodont Company Information
  51. 8.9.2 Septodont Business Overview
  52. 8.9.3 Septodont Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Septodont Short-Acting Anesthetic Product Portfolio
  54. 8.9.5 Septodont Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Short-Acting Anesthetic Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie Short-Acting Anesthetic Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 B. Braun
  68. 8.12.1 B. Braun Company Information
  69. 8.12.2 B. Braun Business Overview
  70. 8.12.3 B. Braun Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 B. Braun Short-Acting Anesthetic Product Portfolio
  72. 8.12.5 B. Braun Recent Developments
  73. 8.13 Cisen Pharmaceutical
  74. 8.13.1 Cisen Pharmaceutical Company Information
  75. 8.13.2 Cisen Pharmaceutical Business Overview
  76. 8.13.3 Cisen Pharmaceutical Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio
  78. 8.13.5 Cisen Pharmaceutical Recent Developments
  79. 8.14 Pfizer
  80. 8.14.1 Pfizer Company Information
  81. 8.14.2 Pfizer Business Overview
  82. 8.14.3 Pfizer Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pfizer Short-Acting Anesthetic Product Portfolio
  84. 8.14.5 Pfizer Recent Developments
  85. 8.15 Yingke Biopharmaceutical
  86. 8.15.1 Yingke Biopharmaceutical Company Information
  87. 8.15.2 Yingke Biopharmaceutical Business Overview
  88. 8.15.3 Yingke Biopharmaceutical Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio
  90. 8.15.5 Yingke Biopharmaceutical Recent Developments
  91. 8.16 SSY Group
  92. 8.16.1 SSY Group Company Information
  93. 8.16.2 SSY Group Business Overview
  94. 8.16.3 SSY Group Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 SSY Group Short-Acting Anesthetic Product Portfolio
  96. 8.16.5 SSY Group Recent Developments
  97. 8.17 Baili-Pharm
  98. 8.17.1 Baili-Pharm Company Information
  99. 8.17.2 Baili-Pharm Business Overview
  100. 8.17.3 Baili-Pharm Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Baili-Pharm Short-Acting Anesthetic Product Portfolio
  102. 8.17.5 Baili-Pharm Recent Developments
  103. 8.18 Eisai
  104. 8.18.1 Eisai Company Information
  105. 8.18.2 Eisai Business Overview
  106. 8.18.3 Eisai Short-Acting Anesthetic Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Eisai Short-Acting Anesthetic Product Portfolio
  108. 8.18.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Short-Acting Anesthetic Value Chain Analysis
  2. 9.1.1 Short-Acting Anesthetic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Short-Acting Anesthetic Production Mode & Process
  6. 9.2 Short-Acting Anesthetic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Short-Acting Anesthetic Distributors
  9. 9.2.3 Short-Acting Anesthetic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst